{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:48:21Z","timestamp":1787237301285,"version":"build-2736575974"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T00:00:00Z","timestamp":1501027200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nutr"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00394-017-1510-3","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T12:52:08Z","timestamp":1501073528000},"page":"23-36","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Public health relevance of drug\u2013nutrition interactions"],"prefix":"10.1007","volume":"56","author":[{"given":"Szabolcs","family":"P\u00e9ter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerjan","family":"Navis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.","family":"de Borst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"von Schacky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Claire B.","family":"van Orten-Luiten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Zhernakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renger F.","family":"Witkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Janse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan J. L.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Eggersdorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,26]]},"reference":[{"issue":"12","key":"1510_CR1","doi-asserted-by":"publisher","first-page":"6076","DOI":"10.3390\/nu6126076","volume":"6","author":"S Peter","year":"2014","unstructured":"Peter S, Eggersdorfer M, van Asselt D, Buskens E, Detzel P, Freijer K, Koletzko B, Kraemer K, Kuipers F, Neufeld L, Obeid R, Wieser S, Zittermann A, Weber P (2014) Selected nutrients and their implications for health and disease across the lifespan: a roadmap. Nutrients 6(12):6076\u20136094. doi: 10.3390\/nu6126076","journal-title":"Nutrients"},{"issue":"12","key":"1510_CR2","doi-asserted-by":"publisher","first-page":"10491","DOI":"10.3390\/nu7125547","volume":"7","author":"S Peter","year":"2015","unstructured":"Peter S, Saris WH, Mathers JC, Feskens E, Schols A, Navis G, Kuipers F, Weber P, Eggersdorfer M (2015) Nutrient status assessment in individuals and populations for healthy aging-statement from an expert workshop. Nutrients 7(12):10491\u201310500. doi: 10.3390\/nu7125547","journal-title":"Nutrients"},{"issue":"7","key":"1510_CR3","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.3390\/nu7075266","volume":"7","author":"B Troesch","year":"2015","unstructured":"Troesch B, Biesalski HK, Bos R, Buskens E, Calder PC, Saris WH, Spieldenner J, Verkade HJ, Weber P, Eggersdorfer M (2015) Increased intake of foods with high nutrient density can help to break the intergenerational cycle of malnutrition and obesity. Nutrients 7(7):6016\u20136037. doi: 10.3390\/nu7075266","journal-title":"Nutrients"},{"issue":"9912","key":"1510_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0140-6736(13)62227-8","volume":"383","author":"JP Ioannidis","year":"2014","unstructured":"Ioannidis JP, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, Schulz KF, Tibshirani R (2014) Increasing value and reducing waste in research design, conduct, and analysis. Lancet 383(9912):166\u2013175. doi: 10.1016\/S0140-6736(13)62227-8","journal-title":"Lancet"},{"issue":"6","key":"1510_CR5","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3109\/07853890.2015.1073347","volume":"47","author":"LM Meems","year":"2015","unstructured":"Meems LM, de Borst MH, Postma DS, Vonk JM, Kremer HP, Schuttelaar ML, Rosmalen JG, Weersma RK, Wolffenbuttel BH, Scholtens S, Stolk RP, Kema IP, Navis G, Khan MA, van der Harst P, de Boer RA (2015) Low levels of vitamin D are associated with multimorbidity: results from the LifeLines Cohort Study. Ann Med 47(6):474\u2013481. doi: 10.3109\/07853890.2015.1073347","journal-title":"Ann Med"},{"issue":"3","key":"1510_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1370\/afm.272","volume":"3","author":"M Fortin","year":"2005","unstructured":"Fortin M, Bravo G, Hudon C, Vanasse A, Lapointe L (2005) Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med 3(3):223\u2013228. doi: 10.1370\/afm.272","journal-title":"Ann Fam Med"},{"key":"1510_CR7","volume-title":"Food for the aging population","author":"MM Raats","year":"2016","unstructured":"Raats MM, de Lisette CPGM, Groot Dieneke, van Asselt D (2016) Food for the aging population, 2nd edn. Woodhead Publishing, Elsevier, Duxford","edition":"2"},{"key":"1510_CR8","volume-title":"Deadly medicines and organised crime: How big pharma has corrupted healthcare","year":"2013","unstructured":"Gotzsche PC (ed) (2013) Deadly medicines and organised crime: How big pharma has corrupted healthcare. Radcliffe Publishing Ltd, London"},{"issue":"13","key":"1510_CR9","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/archinternmed.2010.153","volume":"170","author":"G Onder","year":"2010","unstructured":"Onder G, Petrovic M, Tangiisuran B, Meinardi MC, Markito-Notenboom WP, Somers A, Rajkumar C, Bernabei R, van der Cammen TJ (2010) Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65\u00a0years or older: the GerontoNet ADR risk score. Arch Intern Med 170(13):1142\u20131148. doi: 10.1001\/archinternmed.2010.153","journal-title":"Arch Intern Med"},{"key":"1510_CR10","doi-asserted-by":"crossref","DOI":"10.1533\/9781845695484","volume-title":"Food for the ageing population","author":"M Raats","year":"2009","unstructured":"Raats M, de Groot L, van Staveren W (2009) Food for the ageing population, 1st edn. Woodhead Publishing Limited, Cambridge","edition":"1"},{"key":"1510_CR11","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1345\/aph.1P627","volume":"45","author":"SV Tache","year":"2011","unstructured":"Tache SV, Sonnichsen A, Ashcroft DM (2011) Prevalence of adverse drug events in ambulatory care: a systematic review. Ann Pharmacother 45:977\u2013989","journal-title":"Ann Pharmacother"},{"issue":"4","key":"1510_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/pds.1565","volume":"17","author":"CS Hooft van der","year":"2008","unstructured":"van der Hooft CS, Dieleman JP, Siemes C, Aarnoudse AJ, Verhamme KM, Stricker BH, Sturkenboom MC (2008) Adverse drug reaction-related hospitalisations: a population-based cohort study. Pharmacoepidemiol Drug Saf 17(4):365\u2013371. doi: 10.1002\/pds.1565","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"1510_CR13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell L, Shakir SA (2006) Under-reporting of adverse drug reactions: a systematic review. Drug Saf 29(5):385\u2013396","journal-title":"Drug Saf"},{"key":"1510_CR14","volume-title":"Mann\u2019s pharmacovigilance","year":"2014","unstructured":"Andrews EB, Moore N (eds) (2014) Mann\u2019s pharmacovigilance, 3rd edn. Wiley Blackwell, New York","edition":"3"},{"issue":"4","key":"1510_CR15","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jada.2011.09.002","volume":"112","author":"JI Boullata","year":"2012","unstructured":"Boullata JI, Hudson LM (2012) Drug\u2013nutrient interactions: a broad view with implications for practice. J Acad Nutr Diet 112(4):506\u2013517. doi: 10.1016\/j.jada.2011.09.002","journal-title":"J Acad Nutr Diet"},{"issue":"7","key":"1510_CR16","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/ejcn.2014.75","volume":"68","author":"M Chung","year":"2014","unstructured":"Chung M, van Buul VJ, Wilms E, Nellessen N, Brouns FJPH (2014) Nutrition education in European medical schools: results of an international survey. Eur J Clin Nutr 68(7):844\u2013846. doi: 10.1038\/ejcn.2014.75","journal-title":"Eur J Clin Nutr"},{"issue":"7","key":"1510_CR17","doi-asserted-by":"publisher","first-page":"e1001023","DOI":"10.1371\/journal.pgen.1001023","volume":"6","author":"MP Schnetz","year":"2010","unstructured":"Schnetz MP, Handoko L, Akhtar-Zaidi B, Bartels CF, Pereira CF, Fisher AG, Adams DJ, Flicek P, Crawford GE, Laframboise T, Tesar P, Wei CL, Scacheri PC (2010) CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression. PLoS Genet 6(7):e1001023. doi: 10.1371\/journal.pgen.1001023","journal-title":"PLoS Genet"},{"issue":"9","key":"1510_CR18","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1097\/ACM.0b013e3181eab71b","volume":"85","author":"KM Adams","year":"2010","unstructured":"Adams KM, Kohlmeier M, Zeisel SH (2010) Nutrition education in U.S. medical schools: latest update of a national survey. Acad Med 85(9):1537\u20131542. doi: 10.1097\/ACM.0b013e3181eab71b","journal-title":"Acad Med"},{"issue":"4","key":"1510_CR19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/jamainternmed.2015.8581","volume":"176","author":"DM Qato","year":"2016","unstructured":"Qato DM, Wilder J, Schumm L, Gillet V, Alexander G (2016) Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the united states, 2005 vs 2011. JAMA Intern Med 176(4):473\u2013482","journal-title":"JAMA Intern Med"},{"key":"1510_CR20","first-page":"1","volume":"42","author":"Q Gu","year":"2010","unstructured":"Gu Q, Dillon CF, Burt VL (2010) Prescription drug use continues to increase: U.S. prescription drug data for 2007\u20132008. NCHS Data Brief 42:1\u20138","journal-title":"NCHS Data Brief"},{"issue":"4","key":"1510_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/jcpt.12075","volume":"38","author":"JI Boullata","year":"2013","unstructured":"Boullata JI (2013) Drug and nutrition interactions: not just food for thought. J Clin Pharm Ther 38(4):269\u2013271. doi: 10.1111\/jcpt.12075","journal-title":"J Clin Pharm Ther"},{"issue":"23","key":"1510_CR22","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1200\/JCO.2007.12.0758","volume":"25","author":"MJ Ratain","year":"2007","unstructured":"Ratain MJ, Cohen EE (2007) The value meal: how to save $1,700 per month or more on lapatinib. J Clin Oncol 25(23):3397\u20133398. doi: 10.1200\/JCO.2007.12.0758","journal-title":"J Clin Oncol"},{"issue":"9","key":"1510_CR23","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1200\/JCO.2009.24.1281","volume":"28","author":"CJ Ryan","year":"2010","unstructured":"Ryan CJ, Smith MR, Fong L, Rosenberg JE, Kantoff P, Raynaud F, Martins V, Lee G, Kheoh T, Kim J, Molina A, Small EJ (2010) Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy. J Clin Oncol 28(9):1481\u20131488. doi: 10.1200\/JCO.2009.24.1281","journal-title":"J Clin Oncol"},{"issue":"7","key":"1510_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s40266-014-0180-6","volume":"31","author":"J Peklar","year":"2014","unstructured":"Peklar J, Henman MC, Kos M, Richardson K, Kenny RA (2014) Concurrent use of drugs and supplements in a community-dwelling population aged 50\u00a0years or more: potential benefits and risks. Drugs Aging 31(7):527\u2013540. doi: 10.1007\/s40266-014-0180-6","journal-title":"Drugs Aging"},{"issue":"3","key":"1510_CR25","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1001\/jamaoncol.2015.0388","volume":"1","author":"LG Daenen","year":"2015","unstructured":"Daenen LG, Cirkel GA, Houthuijzen JM, Gerrits J, Oosterom I, Roodhart JM, van Tinteren H, Ishihara K, Huitema AD, Verhoeven-Duif NM, Voest EE (2015) Increased plasma levels of chemoresistance-inducing fatty acid 16:4(n-3) after consumption of fish and fish oil. JAMA Oncol 1(3):350\u2013358. doi: 10.1001\/jamaoncol.2015.0388","journal-title":"JAMA Oncol"},{"issue":"3","key":"1510_CR26","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.yrtph.2015.10.009","volume":"73","author":"A Boer de","year":"2015","unstructured":"de Boer A, van Hunsel F, Bast A (2015) Adverse food\u2013drug interactions. Regul Toxicol Pharmacol 73(3):859\u2013865. doi: 10.1016\/j.yrtph.2015.10.009","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1","key":"1510_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MCO.0b013e32834d155a","volume":"15","author":"J Jyrkka","year":"2012","unstructured":"Jyrkka J, Mursu J, Enlund H, Lonnroos E (2012) Polypharmacy and nutritional status in elderly people. Curr Opin Clin Nutr Metab Care 15(1):1\u20136. doi: 10.1097\/MCO.0b013e32834d155a","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"4","key":"1510_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/21551197.2012.729902","volume":"31","author":"R Heuberger","year":"2012","unstructured":"Heuberger R (2012) Polypharmacy and food\u2013drug interactions among older persons: a review. J Nutr Gerontol Geriatr 31(4):325\u2013403. doi: 10.1080\/21551197.2012.729902","journal-title":"J Nutr Gerontol Geriatr"},{"issue":"5","key":"1510_CR29","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00228-016-2016-2","volume":"72","author":"AC Orten-Luiten van","year":"2016","unstructured":"van Orten-Luiten AC, Janse A, Dhonukshe-Rutten RA, Witkamp RF (2016) Vitamin D deficiency as adverse drug reaction? A cross-sectional study in Dutch geriatric outpatients. Eur J Clin Pharmacol 72(5):605\u2013614. doi: 10.1007\/s00228-016-2016-2","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"1510_CR30","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4161\/derm.20731","volume":"4","author":"U Grober","year":"2012","unstructured":"Grober U, Kisters K (2012) Influence of drugs on vitamin D and calcium metabolism. Dermatoendocrinology 4(2):158\u2013166. doi: 10.4161\/derm.20731","journal-title":"Dermatoendocrinology"},{"issue":"9","key":"1510_CR31","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3109\/14767058.2011.648672","volume":"25","author":"W Holzgreve","year":"2012","unstructured":"Holzgreve W, Pietrzik K, Koletzko B, Eckmann-Scholz C (2012) Adding folate to the contraceptive pill: a new concept for the prevention of neural tube defects. J Matern Fetal Neonatal Med 25(9):1529\u20131536. doi: 10.3109\/14767058.2011.648672","journal-title":"J Matern Fetal Neonatal Med"},{"key":"1510_CR32","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114515002081","author":"CL Ars","year":"2016","unstructured":"Ars CL, Nijs IM, Marroun HE, Muetzel R, Schmidt M, Steenweg-de Graaff J, van der Lugt A, Jaddoe VW, Hofman A, Steegers EA, Verhulst FC, Tiemeier H, White T (2016) Prenatal folate, homocysteine and vitamin B12 levels and child brain volumes, cognitive development and psychological functioning: the Generation R Study. Br J Nutr. doi: 10.1017\/S0007114515002081","journal-title":"Br J Nutr"},{"key":"1510_CR33","doi-asserted-by":"publisher","first-page":"CD007950","DOI":"10.1002\/14651858.CD007950.pub2","volume":"10","author":"LM De-Regil","year":"2010","unstructured":"De-Regil LM, Fernandez-Gaxiola AC, Dowswell T, Pena-Rosas JP (2010) Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev 10:CD007950. doi: 10.1002\/14651858.CD007950.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"21","key":"1510_CR34","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1001\/jama.1995.03530210052030","volume":"274","author":"LE Daly","year":"1995","unstructured":"Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM (1995) Folate levels and neural tube defects. Implications for prevention. JAMA 274(21):1698\u20131702","journal-title":"JAMA"},{"issue":"5","key":"1510_CR35","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1701-2163(15)30258-9","volume":"37","author":"M Shere","year":"2015","unstructured":"Shere M, Bapat P, Nickel C, Kapur B, Koren G (2015) Association between use of oral contraceptives and folate status: a systematic review and meta-analysis. J Obstet Gynaecol Can 37(5):430\u2013438","journal-title":"J Obstet Gynaecol Can"},{"issue":"2","key":"1510_CR36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00003495-198530020-00003","volume":"30","author":"DG Lambie","year":"1985","unstructured":"Lambie DG, Johnson RH (1985) Drugs and folate metabolism. Drugs 30(2):145\u2013155","journal-title":"Drugs"},{"issue":"10","key":"1510_CR37","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.1753-4887.2011.00419.x","volume":"69","author":"SM Wilson","year":"2011","unstructured":"Wilson SM, Bivins BN, Russell KA, Bailey LB (2011) Oral contraceptive use: impact on folate, vitamin B(6), and vitamin B(1)(2) status. Nutr Rev 69(10):572\u2013583. doi: 10.1111\/j.1753-4887.2011.00419.x","journal-title":"Nutr Rev"},{"issue":"1","key":"1510_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.contraception.2011.05.013","volume":"85","author":"S Bart Sr","year":"2012","unstructured":"Bart S Sr, Marr J, Diefenbach K, Trummer D, Sampson-Landers C (2012) Folate status and homocysteine levels during a 24-week oral administration of a folate-containing oral contraceptive: a randomized, double-blind, active-controlled, parallel-group, US-based multicenter study. Contraception 85(1):42\u201350. doi: 10.1016\/j.contraception.2011.05.013","journal-title":"Contraception"},{"key":"1510_CR39","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2147\/IJWH.S37254","volume":"5","author":"K Diefenbach","year":"2013","unstructured":"Diefenbach K, Trummer D, Ebert F, Lissy M, Koch M, Rohde B, Blode H (2013) EE-drospirenone-levomefolate calcium versus EE-drospirenone\u00a0+\u00a0folic acid: folate status during 24\u00a0weeks of treatment and over 20\u00a0weeks following treatment cessation. Int J Womens Health 5:149\u2013163. doi: 10.2147\/IJWH.S37254","journal-title":"Int J Womens Health"},{"issue":"6","key":"1510_CR40","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1701-2163(15)30229-2","volume":"37","author":"M Shere","year":"2015","unstructured":"Shere M, Bapat P, Nickel C, Kapur B, Koren G (2015) The effectiveness of folate-fortified oral contraceptives in maintaining optimal folate levels to protect against neural tube defects: a systematic review. J Obstet Gynaecol Can 37(6):527\u2013533","journal-title":"J Obstet Gynaecol Can"},{"issue":"4","key":"1510_CR41","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1681\/ASN.2011111115","volume":"23","author":"MM Mitsnefes","year":"2012","unstructured":"Mitsnefes MM (2012) Cardiovascular disease in children with chronic kidney disease. J Am Soc Nephrol 23(4):578\u2013585. doi: 10.1681\/ASN.2011111115","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1510_CR42","doi-asserted-by":"publisher","first-page":"e35316","DOI":"10.1371\/journal.pone.0035316","volume":"7","author":"N Schmidt","year":"2012","unstructured":"Schmidt N, Brandsch C, Kuhne H, Thiele A, Hirche F, Stangl GI (2012) Vitamin D receptor deficiency and low vitamin D diet stimulate aortic calcification and osteogenic key factor expression in mice. PLoS One 7(4):e35316. doi: 10.1371\/journal.pone.0035316","journal-title":"PLoS One"},{"issue":"8","key":"1510_CR43","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1681\/ASN.2007080902","volume":"19","author":"S Mathew","year":"2008","unstructured":"Mathew S, Lund RJ, Chaudhary LR, Geurs T, Hruska KA (2008) Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol 19(8):1509\u20131519. doi: 10.1681\/ASN.2007080902","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1510_CR44","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1161\/HYPERTENSIONAHA.115.05837","volume":"66","author":"AJ Ballegooijen van","year":"2015","unstructured":"van Ballegooijen AJ, Gansevoort RT, Lambers-Heerspink HJ, de Zeeuw D, Visser M, Brouwer IA, Kema IP, de Borst MH, Bakker SJ, Joosten MM (2015) Plasma 1,25-dihydroxyvitamin D and the risk of developing hypertension: the prevention of renal and vascular end-stage disease study. Hypertension 66(3):563\u2013570. doi: 10.1161\/HYPERTENSIONAHA.115.05837","journal-title":"Hypertension"},{"key":"1510_CR45","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016040407","author":"CA Keyzer","year":"2016","unstructured":"Keyzer CA, van Breda GF, Vervloet MG, de Jong MA, Laverman GD, Hemmelder MH, Janssen WM, Lambers Heerspink HJ, Kwakernaak AJ, Bakker SJ, Navis G, de Borst MH, Holland Nephrology Study Network (2016) Effects of vitamin D receptor activation and dietary sodium restriction on residual albuminuria in CKD: the ViRTUE-CKD trial. J Am Soc Nephrol. doi: 10.1681\/ASN.2016040407","journal-title":"J Am Soc Nephrol"},{"key":"1510_CR46","doi-asserted-by":"publisher","first-page":"g3656","DOI":"10.1136\/bmj.g3656","volume":"348","author":"B Schottker","year":"2014","unstructured":"Schottker B, Jorde R, Peasey A, Thorand B, Jansen EH, Groot L, Streppel M, Gardiner J, Ordonez-Mena JM, Perna L, Wilsgaard T, Rathmann W, Feskens E, Kampman E, Siganos G, Njolstad I, Mathiesen EB, Kubinova R, Pajak A, Topor-Madry R, Tamosiunas A, Hughes M, Kee F, Bobak M, Trichopoulou A, Boffetta P, Brenner H, Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (2014) Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ 348:g3656. doi: 10.1136\/bmj.g3656","journal-title":"BMJ"},{"key":"1510_CR47","doi-asserted-by":"publisher","first-page":"CD007470","DOI":"10.1002\/14651858.CD007470.pub3","volume":"1","author":"G Bjelakovic","year":"2014","unstructured":"Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C (2014) Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 1:CD007470. doi: 10.1002\/14651858.CD007470.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"1510_CR48","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S2213-8587(13)70212-2","volume":"2","author":"MJ Bolland","year":"2014","unstructured":"Bolland MJ, Grey A, Gamble GD, Reid IR (2014) The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2(4):307\u2013320. doi: 10.1016\/S2213-8587(13)70212-2","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"1510_CR49","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S2213-8587(14)70096-8","volume":"2","author":"HA Bischoff-Ferrari","year":"2014","unstructured":"Bischoff-Ferrari HA, Orav EJ, Willett WC, Dawson-Hughes B (2014) The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes. Lancet Diabetes Endocrinol 2(5):363\u2013364. doi: 10.1016\/S2213-8587(14)70096-8","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"1510_CR50","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S2213-8587(14)70095-6","volume":"2","author":"P Anagnostis","year":"2014","unstructured":"Anagnostis P, Karras SN, Athyros VG, Annweiler C, Karagiannis A (2014) The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes. Lancet Diabetes Endocrinol 2(5):362\u2013363. doi: 10.1016\/S2213-8587(14)70095-6","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"1510_CR51","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S2213-8587(14)70098-1","volume":"2","author":"WB Grant","year":"2014","unstructured":"Grant WB (2014) The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes. Lancet Diabetes Endocrinol 2(5):364. doi: 10.1016\/S2213-8587(14)70098-1","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6620","key":"1510_CR52","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/386078a0","volume":"386","author":"G Luo","year":"1997","unstructured":"Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G (1997) Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386(6620):78\u201381. doi: 10.1038\/386078a0","journal-title":"Nature"},{"issue":"6","key":"1510_CR53","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1159\/000075344","volume":"40","author":"HM Spronk","year":"2003","unstructured":"Spronk HM, Soute BA, Schurgers LJ, Thijssen HH, De Mey JG, Vermeer C (2003) Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. J Vasc Res 40(6):531\u2013537","journal-title":"J Vasc Res"},{"issue":"5","key":"1510_CR54","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/ki.2012.477","volume":"83","author":"KM McCabe","year":"2013","unstructured":"McCabe KM, Booth SL, Fu X, Shobeiri N, Pang JJ, Adams MA, Holden RM (2013) Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease. Kidney Int 83(5):835\u2013844. doi: 10.1038\/ki.2012.477","journal-title":"Kidney Int"},{"issue":"11","key":"1510_CR55","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1161\/ATVBAHA.113.302244","volume":"33","author":"T Kruger","year":"2013","unstructured":"Kruger T, Oelenberg S, Kaesler N, Schurgers LJ, van de Sandt AM, Boor P, Schlieper G, Brandenburg VM, Fekete BC, Veulemans V, Ketteler M, Vermeer C, Jahnen-Dechent W, Floege J, Westenfeld R (2013) Warfarin induces cardiovascular damage in mice. Arterioscler Thromb Vasc Biol 33(11):2618\u20132624. doi: 10.1161\/ATVBAHA.113.302244","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1510_CR56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1161\/HYPERTENSIONAHA.115.05177","volume":"66","author":"E Pivin","year":"2015","unstructured":"Pivin E, Ponte B, Pruijm M, Ackermann D, Guessous I, Ehret G, Liu YP, Drummen NE, Knapen MH, Pechere-Bertschi A, Paccaud F, Mohaupt M, Vermeer C, Staessen JA, Vogt B, Martin PY, Burnier M, Bochud M (2015) Inactive matrix Gla-protein is associated with arterial stiffness in an adult population-based study. Hypertension 66(1):85\u201392. doi: 10.1161\/HYPERTENSIONAHA.115.05177","journal-title":"Hypertension"},{"issue":"5","key":"1510_CR57","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1365-2796.2010.02264.x","volume":"268","author":"T Ueland","year":"2010","unstructured":"Ueland T, Gullestad L, Dahl CP, Aukrust P, Aakhus S, Solberg OG, Vermeer C, Schurgers LJ (2010) Undercarboxylated matrix Gla protein is associated with indices of heart failure and mortality in symptomatic aortic stenosis. J Intern Med 268(5):483\u2013492. doi: 10.1111\/j.1365-2796.2010.02264.x","journal-title":"J Intern Med"},{"issue":"1","key":"1510_CR58","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.atherosclerosis.2014.04.027","volume":"235","author":"O Mayer Jr","year":"2014","unstructured":"Mayer O Jr, Seidlerova J, Bruthans J, Filipovsky J, Timoracka K, Vanek J, Cerna L, Wohlfahrt P, Cifkova R, Theuwissen E, Vermeer C (2014) Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease. Atherosclerosis 235(1):162\u2013168. doi: 10.1016\/j.atherosclerosis.2014.04.027","journal-title":"Atherosclerosis"},{"issue":"4","key":"1510_CR59","doi-asserted-by":"publisher","first-page":"568","DOI":"10.2215\/CJN.07081009","volume":"5","author":"LJ Schurgers","year":"2010","unstructured":"Schurgers LJ, Barreto DV, Barreto FC, Liabeuf S, Renard C, Magdeleyns EJ, Vermeer C, Choukroun G, Massy ZA (2010) The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin J Am Soc Nephrol 5(4):568\u2013575. doi: 10.2215\/CJN.07081009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"1510_CR60","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1053\/j.ajkd.2014.09.014","volume":"65","author":"CA Keyzer","year":"2015","unstructured":"Keyzer CA, Vermeer C, Joosten MM, Knapen MH, Drummen NE, Navis G, Bakker SJ, de Borst MH (2015) Vitamin K status and mortality after kidney transplantation: a cohort study. Am J Kidney Dis 65(3):474\u2013483. doi: 10.1053\/j.ajkd.2014.09.014","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"1510_CR61","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/ndt\/gft459","volume":"29","author":"T Krueger","year":"2014","unstructured":"Krueger T, Schlieper G, Schurgers L, Cornelis T, Cozzolino M, Jacobi J, Jadoul M, Ketteler M, Rump LC, Stenvinkel P, Westenfeld R, Wiecek A, Reinartz S, Hilgers RD, Floege J (2014) Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol. Nephrol Dial Transplant 29(9):1633\u20131638. doi: 10.1093\/ndt\/gft459","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"1510_CR62","doi-asserted-by":"publisher","first-page":"8905","DOI":"10.3390\/nu7115443","volume":"7","author":"LM Vossen","year":"2015","unstructured":"Vossen LM, Schurgers LJ, van Varik BJ, Kietselaer BL, Vermeer C, Meeder JG, Rahel BM, van Cauteren YJ, Hoffland GA, Rennenberg RJ, Reesink KD, de Leeuw PW, Kroon AA (2015) Menaquinone-7 supplementation to reduce vascular calcification in patients with coronary artery disease: rationale and study protocol (VitaK-CAC Trial). Nutrients 7(11):8905\u20138915. doi: 10.3390\/nu7115443","journal-title":"Nutrients"},{"issue":"2","key":"1510_CR63","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1681\/ASN.2010040339","volume":"22","author":"G Schlieper","year":"2011","unstructured":"Schlieper G, Westenfeld R, Kruger T, Cranenburg EC, Magdeleyns EJ, Brandenburg VM, Djuric Z, Damjanovic T, Ketteler M, Vermeer C, Dimkovic N, Floege J, Schurgers LJ (2011) Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. J Am Soc Nephrol 22(2):387\u2013395. doi: 10.1681\/ASN.2010040339","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"1510_CR64","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1093\/jn\/134.11.3100","volume":"134","author":"JM Geleijnse","year":"2004","unstructured":"Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, Hofman A, Witteman JC (2004) Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 134(11):3100\u20133105","journal-title":"J Nutr"},{"issue":"10","key":"1510_CR65","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1681\/ASN.2012030240","volume":"23","author":"A Pasch","year":"2012","unstructured":"Pasch A, Farese S, Graber S, Wald J, Richtering W, Floege J, Jahnen-Dechent W (2012) Nanoparticle-based test measures overall propensity for calcification in serum. J Am Soc Nephrol 23(10):1744\u20131752. doi: 10.1681\/ASN.2012030240","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1510_CR66","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1681\/ASN.2013060635","volume":"25","author":"ER Smith","year":"2014","unstructured":"Smith ER, Ford ML, Tomlinson LA, Bodenham E, McMahon LP, Farese S, Rajkumar C, Holt SG, Pasch A (2014) Serum calcification propensity predicts all-cause mortality in predialysis CKD. J Am Soc Nephrol 25(2):339\u2013348. doi: 10.1681\/ASN.2013060635","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1510_CR67","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1681\/ASN.2014070670","volume":"27","author":"CA Keyzer","year":"2016","unstructured":"Keyzer CA, de Borst MH, van den Berg E, Jahnen-Dechent W, Arampatzis S, Farese S, Bergmann IP, Floege J, Navis G, Bakker SJ, van Goor H, Eisenberger U, Pasch A (2016) Calcification propensity and survival among renal transplant recipients. J Am Soc Nephrol 27(1):239\u2013248. doi: 10.1681\/ASN.2014070670","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"1510_CR68","doi-asserted-by":"publisher","first-page":"e76632","DOI":"10.1371\/journal.pone.0076632","volume":"8","author":"E Archer","year":"2013","unstructured":"Archer E, Hand GA, Blair SN (2013) Validity of U.S. nutritional surveillance: National Health and Nutrition Examination Survey caloric energy intake data, 1971\u20132010. PLoS One 8(10):e76632. doi: 10.1371\/journal.pone.0076632","journal-title":"PLoS One"},{"issue":"5","key":"1510_CR69","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1017\/S0007114510001054","volume":"104","author":"A Kohler","year":"2010","unstructured":"Kohler A, Bittner D, Low A, von Schacky C (2010) Effects of a convenience drink fortified with n-3 fatty acids on the n-3 index. Br J Nutr 104(5):729\u2013736. doi: 10.1017\/S0007114510001054","journal-title":"Br J Nutr"},{"key":"1510_CR70","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13058-015-0571-6","volume":"17","author":"CJ Fabian","year":"2015","unstructured":"Fabian CJ, Kimler BF, Hursting SD (2015) Omega-3 fatty acids for breast cancer prevention and survivorship. Breast Cancer Res 17:62. doi: 10.1186\/s13058-015-0571-6","journal-title":"Breast Cancer Res"},{"issue":"6","key":"1510_CR71","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jacl.2012.01.002","volume":"6","author":"MH Davidson","year":"2012","unstructured":"Davidson MH, Johnson J, Rooney MW, Kyle ML, Kling DF (2012) A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova((R)) compared to Lovaza((R)) in a pharmacokinetic single-dose evaluation) study. J Clin Lipidol 6(6):573\u2013584. doi: 10.1016\/j.jacl.2012.01.002","journal-title":"J Clin Lipidol"},{"issue":"Suppl 1","key":"1510_CR72","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.2459\/01.JCM.0000289274.64933.45","volume":"8","author":"WS Harris","year":"2007","unstructured":"Harris WS (2007) International recommendations for consumption of long-chain omega-3 fatty acids. J Cardiovasc Med (Hagerstown) 8(Suppl 1):S50\u2013S52. doi: 10.2459\/01.JCM.0000289274.64933.45","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"1510_CR73","volume-title":"The omega-3 fatty acid deficiency syndrome: opportunities for disease prevention","author":"WS Harris","year":"2013","unstructured":"Harris WS, von Schacky C, Park Y (2013) Standardizing methods for assessing omega-3 fatty acid biostatus. In: McNamara RK (ed) The omega-3 fatty acid deficiency syndrome: opportunities for disease prevention. Nova Science Publishers, USA"},{"issue":"12","key":"1510_CR74","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1161\/01.CIR.0000142292.10048.B2","volume":"110","author":"WS Harris","year":"2004","unstructured":"Harris WS, Sands SA, Windsor SL, Ali HA, Stevens TL, Magalski A, Porter CB, Borkon AM (2004) Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 110(12):1645\u20131649. doi: 10.1161\/01.CIR.0000142292.10048.B2","journal-title":"Circulation"},{"issue":"43","key":"1510_CR75","doi-asserted-by":"publisher","first-page":"32720","DOI":"10.1074\/jbc.M110.118406","volume":"285","author":"C Arnold","year":"2010","unstructured":"Arnold C, Markovic M, Blossey K, Wallukat G, Fischer R, Dechend R, Konkel A, von Schacky C, Luft FC, Muller DN, Rothe M, Schunck WH (2010) Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids. J Biol Chem 285(43):32720\u201332733. doi: 10.1074\/jbc.M110.118406","journal-title":"J Biol Chem"},{"issue":"3","key":"1510_CR76","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.plefa.2014.04.001","volume":"91","author":"EA Gurzell","year":"2014","unstructured":"Gurzell EA, Wiesinger JA, Morkam C, Hemmrich S, Harris WS, Fenton JI (2014) Is the omega-3 index a valid marker of intestinal membrane phospholipid EPA\u00a0+\u00a0DHA content? Prostaglandins Leukot Essent Fatty Acids 91(3):87\u201396. doi: 10.1016\/j.plefa.2014.04.001","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"12","key":"1510_CR77","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1002\/ijc.29675","volume":"137","author":"S Roy","year":"2015","unstructured":"Roy S, Brasky TM, Belury MA, Krishnan S, Cole RM, Marian C, Yee LD, Llanos AA, Freudenheim JL, Shields PG (2015) Associations of erythrocyte omega-3 fatty acids with biomarkers of omega-3 fatty acids and inflammation in breast tissue. Int J Cancer 137(12):2934\u20132946. doi: 10.1002\/ijc.29675","journal-title":"Int J Cancer"},{"key":"1510_CR78","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.plefa.2014.05.004","volume":"92","author":"C Schacky von","year":"2015","unstructured":"von Schacky C (2015) Omega-3 fatty acids in cardiovascular disease\u2014an uphill battle. Prostaglandins Leukot Essent Fatty Acids 92:41\u201347. doi: 10.1016\/j.plefa.2014.05.004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"4","key":"1510_CR79","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.plefa.2014.07.013","volume":"91","author":"BS Muhlhausler","year":"2014","unstructured":"Muhlhausler BS, Gibson RA, Yelland LN, Makrides M (2014) Heterogeneity in cord blood DHA concentration: towards an explanation. Prostaglandins Leukot Essent Fatty Acids 91(4):135\u2013140. doi: 10.1016\/j.plefa.2014.07.013","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"8666","key":"1510_CR80","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(89)90828-3","volume":"2","author":"ML Burr","year":"1989","unstructured":"Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2(8666):757\u2013761","journal-title":"Lancet"},{"issue":"9645","key":"1510_CR81","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(08)61239-8","volume":"372","author":"L Tavazzi","year":"2008","unstructured":"Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G, Gissi HFI (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372(9645):1223\u20131230. doi: 10.1016\/S0140-6736(08)61239-8","journal-title":"Lancet"},{"issue":"9567","key":"1510_CR82","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","volume":"369","author":"M Yokoyama","year":"2007","unstructured":"Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K, Japan EPAlisI (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369(9567):1090\u20131098. doi: 10.1016\/S0140-6736(07)60527-3","journal-title":"Lancet"},{"issue":"3","key":"1510_CR83","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3233\/JAD-150886","volume":"51","author":"N Kulzow","year":"2016","unstructured":"Kulzow N, Witte AV, Kerti L, Grittner U, Schuchardt JP, Hahn A, Floel A (2016) Impact of omega-3 fatty acid supplementation on memory functions in healthy older adults. J Alzheimers Dis 51(3):713\u2013725. doi: 10.3233\/JAD-150886","journal-title":"J Alzheimers Dis"},{"key":"1510_CR84","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.plefa.2014.01.002","volume":"92","author":"RA Haast","year":"2015","unstructured":"Haast RA, Kiliaan AJ (2015) Impact of fatty acids on brain circulation, structure and function. Prostaglandins Leukot Essent Fatty Acids 92:3\u201314. doi: 10.1016\/j.plefa.2014.01.002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"11","key":"1510_CR85","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1093\/cercor\/bht163","volume":"24","author":"AV Witte","year":"2014","unstructured":"Witte AV, Kerti L, Hermannstadter HM, Fiebach JB, Schreiber SJ, Schuchardt JP, Hahn A, Floel A (2014) Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb Cortex 24(11):3059\u20133068. doi: 10.1093\/cercor\/bht163","journal-title":"Cereb Cortex"},{"key":"1510_CR86","unstructured":"Ismail A (2015) Omega-3s and cognition: dosage matters. http:\/\/www.goedomega3.com\/index.php\/blog\/2015\/08\/omega-3s-and-cognition-dosage-matters . Accessed 23 Nov 2016"},{"issue":"12","key":"1510_CR87","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.nutres.2009.10.018","volume":"29","author":"Y Park","year":"2009","unstructured":"Park Y, Park S, Yi H, Kim HY, Kang SJ, Kim J, Ahn H (2009) Low level of n-3 polyunsaturated fatty acids in erythrocytes is a risk factor for both acute ischemic and hemorrhagic stroke in Koreans. Nutr Res 29(12):825\u2013830. doi: 10.1016\/j.nutres.2009.10.018","journal-title":"Nutr Res"},{"issue":"2","key":"1510_CR88","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000337302","volume":"60","author":"HJ Moon","year":"2012","unstructured":"Moon HJ, Kim TH, Byun DW, Park Y (2012) Positive correlation between erythrocyte levels of n-3 polyunsaturated fatty acids and bone mass in postmenopausal Korean women with osteoporosis. Ann Nutr Metab 60(2):146\u2013153. doi: 10.1159\/000337302","journal-title":"Ann Nutr Metab"},{"issue":"1\u20132","key":"1510_CR89","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000353120","volume":"63","author":"AL Lee","year":"2013","unstructured":"Lee AL, Park Y (2013) The association between n-3 polyunsaturated fatty acid levels in erythrocytes and the risk of rheumatoid arthritis in Korean women. Ann Nutr Metab 63(1\u20132):88\u201395. doi: 10.1159\/000353120","journal-title":"Ann Nutr Metab"},{"issue":"3","key":"1510_CR90","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/cbm.1954","volume":"26","author":"A Zaalberg","year":"2016","unstructured":"Zaalberg A, Wielders J, Bulten E, van der Staak C, Wouters A, Nijman H (2016) Relationships of diet-related blood parameters and blood lead levels with psychopathology and aggression in forensic psychiatric inpatients. Crim Behav Ment Health 26(3):196\u2013211. doi: 10.1002\/cbm.1954","journal-title":"Crim Behav Ment Health"},{"issue":"1","key":"1510_CR91","first-page":"151","volume":"13","author":"P Lembke","year":"2014","unstructured":"Lembke P, Capodice J, Hebert K, Swenson T (2014) Influence of omega-3 (n3) index on performance and wellbeing in young adults after heavy eccentric exercise. J Sports Sci Med 13(1):151\u2013156","journal-title":"J Sports Sci Med"},{"key":"1510_CR92","first-page":"3","volume":"26","author":"K Langlois","year":"2015","unstructured":"Langlois K, Ratnayake W (2015) Omega-3 index of Canadian adults. Health Rep 26:3\u201311","journal-title":"Health Rep"},{"key":"1510_CR93","unstructured":"Risikobewertung Bf (2016) Gesundheitliche Bewertung von Nahrungserg\u00e4nzungsmitteln. http:\/\/www.bfr.bund.de\/de\/gesundheitliche_bewertung_von_nahrungsergaenzungsmitteln-945.html . Accessed 23 Nov 2016"},{"issue":"1","key":"1510_CR94","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00380-011-0213-6","volume":"28","author":"S Kurisu","year":"2013","unstructured":"Kurisu S, Ishibashi K, Kato Y, Mitsuba N, Dohi Y, Nishioka K, Kihara Y (2013) Effects of lipid-lowering therapy with strong statin on serum polyunsaturated fatty acid levels in patients with coronary artery disease. Heart Vessels 28(1):34\u201338. doi: 10.1007\/s00380-011-0213-6","journal-title":"Heart Vessels"},{"issue":"4","key":"1510_CR95","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.plefa.2004.06.001","volume":"71","author":"JI Harris","year":"2004","unstructured":"Harris JI, Hibbeln JR, Mackey RH, Muldoon MF (2004) Statin treatment alters serum n-3 and n-6 fatty acids in hypercholesterolemic patients. Prostaglandins Leukot Essent Fatty Acids 71(4):263\u2013269. doi: 10.1016\/j.plefa.2004.06.001","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"1510_CR96","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.plipres.2016.05.001","volume":"63","author":"KD Stark","year":"2016","unstructured":"Stark KD, Van Elswyk ME, Higgins MR, Weatherford CA, Salem N Jr (2016) Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. Prog Lipid Res 63:132\u2013152. doi: 10.1016\/j.plipres.2016.05.001","journal-title":"Prog Lipid Res"},{"issue":"1","key":"1510_CR97","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.amjcard.2012.08.038","volume":"111","author":"T Nozue","year":"2013","unstructured":"Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I (2013) Effects of serum n-3 to n-6 polyunsaturated fatty acids ratios on coronary atherosclerosis in statin-treated patients with coronary artery disease. Am J Cardiol 111(1):6\u201311. doi: 10.1016\/j.amjcard.2012.08.038","journal-title":"Am J Cardiol"},{"issue":"5","key":"1510_CR98","doi-asserted-by":"publisher","first-page":"e62772","DOI":"10.1371\/journal.pone.0062772","volume":"8","author":"A Macchia","year":"2013","unstructured":"Macchia A, Romero M, D\u2019Ettorre A, Tognoni G, Mariani J (2013) Exploratory analysis on the use of statins with or without n-3 PUFA and major events in patients discharged for acute myocardial infarction: an observational retrospective study. PLoS One 8(5):e62772. doi: 10.1371\/journal.pone.0062772","journal-title":"PLoS One"},{"issue":"6A","key":"1510_CR99","doi-asserted-by":"publisher","first-page":"44C","DOI":"10.1016\/j.amjcard.2006.11.021","volume":"99","author":"WS Harris","year":"2007","unstructured":"Harris WS (2007) Expert opinion: omega-3 fatty acids and bleeding-cause for concern? Am J Cardiol 99(6A):44C\u201346C. doi: 10.1016\/j.amjcard.2006.11.021","journal-title":"Am J Cardiol"},{"issue":"1","key":"1510_CR100","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/JTN.0000000000000256","volume":"24","author":"BW Gross","year":"2017","unstructured":"Gross BW, Gillio M, Rinehart CD, Lynch CA, Rogers FB (2017) Omega-3 fatty acid supplementation and warfarin: a lethal combination in traumatic brain injury. J Trauma Nurs 24(1):15\u201318. doi: 10.1097\/JTN.0000000000000256","journal-title":"J Trauma Nurs"},{"issue":"6","key":"1510_CR101","doi-asserted-by":"publisher","first-page":"398","DOI":"10.7326\/M13-1788","volume":"160","author":"R Chowdhury","year":"2014","unstructured":"Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, Franco OH, Butterworth AS, Forouhi NG, Thompson SG, Khaw KT, Mozaffarian D, Danesh J, Di Angelantonio E (2014) Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med 160(6):398\u2013406. doi: 10.7326\/M13-1788","journal-title":"Ann Intern Med"},{"issue":"1","key":"1510_CR102","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/jth.13553","volume":"15","author":"MF Reiner","year":"2017","unstructured":"Reiner MF, Stivala S, Limacher A, Bonetti NR, Mean M, Egloff M, Rodondi N, Aujesky D, von Schacky C, Luscher TF, Camici GG, Beer JH (2017) Omega-3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism. J Thromb Haemost 15(1):47\u201356. doi: 10.1111\/jth.13553","journal-title":"J Thromb Haemost"},{"issue":"1","key":"1510_CR103","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.amjcard.2011.07.063","volume":"109","author":"AC Salisbury","year":"2012","unstructured":"Salisbury AC, Harris WS, Amin AP, Reid KJ, O\u2019Keefe JH Jr, Spertus JA (2012) Relation between red blood cell omega-3 fatty acid index and bleeding during acute myocardial infarction. Am J Cardiol 109(1):13\u201318. doi: 10.1016\/j.amjcard.2011.07.063","journal-title":"Am J Cardiol"},{"key":"1510_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2016.10.026","author":"P Nandivada","year":"2016","unstructured":"Nandivada P, Anez-Bustillos L, O\u2019Loughlin AA, Mitchell PD, Baker MA, Dao DT, Fell GL, Potemkin AK, Gura KM, Neufeld EJ, Puder M (2016) Risk of post-procedural bleeding in children on intravenous fish oil. Am J Surg. doi: 10.1016\/j.amjsurg.2016.10.026","journal-title":"Am J Surg"},{"key":"1510_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2016.12.018","author":"I Nakagawa","year":"2016","unstructured":"Nakagawa I, Yokoyama S, Omoto K, Takeshima Y, Matsuda R, Nishimura F, Yamada S, Yokota H, Motoyama Y, Park YS, Nakase H (2016) Omega-3 fatty acid Ethyl Esters suppress cerebral vasospasm and improve clinical outcome following aneurysmal subarachnoid hemorrhage. World Neurosurg. doi: 10.1016\/j.wneu.2016.12.018","journal-title":"World Neurosurg"},{"issue":"7216","key":"1510_CR106","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/nature07336","volume":"455","author":"L Wen","year":"2008","unstructured":"Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, Gordon JI, Chervonsky AV (2008) Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455(7216):1109\u20131113. doi: 10.1038\/nature07336","journal-title":"Nature"},{"issue":"Suppl 1","key":"1510_CR107","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1073\/pnas.1000082107","volume":"108","author":"YK Lee","year":"2011","unstructured":"Lee YK, Menezes JS, Umesaki Y, Mazmanian SK (2011) Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 108(Suppl 1):4615\u20134622. doi: 10.1073\/pnas.1000082107","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"1510_CR108","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1136\/gutjnl-2013-304833","volume":"63","author":"K Machiels","year":"2014","unstructured":"Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, Eeckhaut V, Ballet V, Claes K, Van Immerseel F, Verbeke K, Ferrante M, Verhaegen J, Rutgeerts P, Vermeire S (2014) A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63(8):1275\u20131283. doi: 10.1136\/gutjnl-2013-304833","journal-title":"Gut"},{"key":"1510_CR109","doi-asserted-by":"publisher","first-page":"e01202","DOI":"10.7554\/eLife.01202","volume":"2","author":"JU Scher","year":"2013","unstructured":"Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, Rostron T, Cerundolo V, Pamer EG, Abramson SB, Huttenhower C, Littman DR (2013) Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2:e01202. doi: 10.7554\/eLife.01202","journal-title":"Elife"},{"issue":"4","key":"1510_CR110","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/ije\/dyu229","volume":"44","author":"S Scholtens","year":"2015","unstructured":"Scholtens S, Smidt N, Swertz MA, Bakker SJ, Dotinga A, Vonk JM, van Dijk F, van Zon SK, Wijmenga C, Wolffenbuttel BH, Stolk RP (2015) Cohort profile: LifeLines, a three-generation cohort study and biobank. Int J Epidemiol 44(4):1172\u20131180. doi: 10.1093\/ije\/dyu229","journal-title":"Int J Epidemiol"},{"issue":"8","key":"1510_CR111","doi-asserted-by":"publisher","first-page":"e006772","DOI":"10.1136\/bmjopen-2014-006772","volume":"5","author":"EF Tigchelaar","year":"2015","unstructured":"Tigchelaar EF, Zhernakova A, Dekens JA, Hermes G, Baranska A, Mujagic Z, Swertz MA, Munoz AM, Deelen P, Cenit MC, Franke L, Scholtens S, Stolk RP, Wijmenga C, Feskens EJ (2015) Cohort profile: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics. BMJ Open 5(8):e006772. doi: 10.1136\/bmjopen-2014-006772","journal-title":"BMJ Open"},{"issue":"6285","key":"1510_CR112","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1126\/science.aad3369","volume":"352","author":"A Zhernakova","year":"2016","unstructured":"Zhernakova A, Kurilshikov A, Bonder MJ, Tigchelaar EF, Schirmer M, Vatanen T, Mujagic Z, Vila AV, Falony G, Vieira-Silva S, Wang J, Imhann F, Brandsma E, Jankipersadsing SA, Joossens M, Cenit MC, Deelen P, Swertz MA, LifeLines cohort study, Weersma RK, Feskens EJ, Netea MG, Gevers D, Jonkers D, Franke L, Aulchenko YS, Huttenhower C, Raes J, Hofker MH, Xavier RJ, Wijmenga C, Fu J (2016) Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352(6285):565\u2013569. doi: 10.1126\/science.aad3369","journal-title":"Science"},{"issue":"9528","key":"1510_CR113","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/S0140-6736(06)68932-0","volume":"367","author":"P Moayyedi","year":"2006","unstructured":"Moayyedi P, Talley NJ (2006) Gastro-oesophageal reflux disease. Lancet 367(9528):2086\u20132100. doi: 10.1016\/S0140-6736(06)68932-0","journal-title":"Lancet"},{"key":"1510_CR114","volume-title":"Facts and figures\u00a02014","author":"Statistics FfP","year":"2014","unstructured":"Statistics FfP (2014) Facts and figures\u00a02014. Foundation for Pharmaceutical Statistics, The Hague"},{"issue":"5","key":"1510_CR115","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1001\/jamainternmed.2015.42","volume":"175","author":"EG McDonald","year":"2015","unstructured":"McDonald EG, Milligan J, Frenette C, Lee TC (2015) Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection. JAMA Intern Med 175(5):784\u2013791. doi: 10.1001\/jamainternmed.2015.42","journal-title":"JAMA Intern Med"},{"issue":"32","key":"1510_CR116","doi-asserted-by":"crossref","first-page":"20873","DOI":"10.2807\/1560-7917.ES2014.19.32.20873","volume":"19","author":"M Bouwknegt","year":"2014","unstructured":"Bouwknegt M, van Pelt W, Kubbinga ME, Weda M, Havelaar AH (2014) Potential association between the recent increase in campylobacteriosis incidence in the Netherlands and proton-pump inhibitor use\u2014an ecological study. Euro Surveill 19(32):20873","journal-title":"Euro Surveill"},{"issue":"9","key":"1510_CR117","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1111\/j.1572-0241.2007.01275.x","volume":"102","author":"J Leonard","year":"2007","unstructured":"Leonard J, Marshall JK, Moayyedi P (2007) Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 102(9):2047\u20132056. doi: 10.1111\/j.1572-0241.2007.01275.x (quiz 2057)","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"1510_CR118","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/ajg.2012.179","volume":"107","author":"S Janarthanan","year":"2012","unstructured":"Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN (2012) Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol 107(7):1001\u20131010. doi: 10.1038\/ajg.2012.179","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"1510_CR119","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1161\/CIRCRESAHA.115.306807","volume":"117","author":"J Fu","year":"2015","unstructured":"Fu J, Bonder MJ, Cenit MC, Tigchelaar EF, Maatman A, Dekens JA, Brandsma E, Marczynska J, Imhann F, Weersma RK, Franke L, Poon TW, Xavier RJ, Gevers D, Hofker MH, Wijmenga C, Zhernakova A (2015) The gut microbiome contributes to a substantial proportion of the variation in blood lipids. Circ Res 117(9):817\u2013824. doi: 10.1161\/CIRCRESAHA.115.306807","journal-title":"Circ Res"},{"issue":"6","key":"1510_CR120","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/MNH.0000000000000073","volume":"23","author":"JK Humalda","year":"2014","unstructured":"Humalda JK, Navis G (2014) Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease. Curr Opin Nephrol Hypertens 23(6):533\u2013540. doi: 10.1097\/MNH.0000000000000073","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"7","key":"1510_CR121","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1681\/ASN.2012010099","volume":"23","author":"HL Heerspink","year":"2012","unstructured":"Heerspink HL, Ritz E (2012) Sodium chloride intake: is lower always better? J Am Soc Nephrol 23(7):1136\u20131139. doi: 10.1681\/ASN.2012010099","journal-title":"J Am Soc Nephrol"}],"container-title":["European Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00394-017-1510-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-017-1510-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-017-1510-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T12:57:24Z","timestamp":1569934644000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00394-017-1510-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,26]]},"references-count":121,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["1510"],"URL":"https:\/\/doi.org\/10.1007\/s00394-017-1510-3","relation":{},"ISSN":["1436-6207","1436-6215"],"issn-type":[{"value":"1436-6207","type":"print"},{"value":"1436-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,26]]}}}